Viromed Medical GmbH and terraplasma medical GmbH terminate their cooperation with immediate effect
|
EQS-Ad-hoc: Viromed Medical AG / Key word(s): Miscellaneous Viromed Medical AG: Viromed Medical GmbH and terraplasma medical GmbH terminate their cooperation with immediate effect As part of the previous cooperation, Viromed Medical GmbH held the exclusive distribution rights for a cold plasma device developed by terraplasma medical GmbH in the German-speaking region (Germany, Austria, Switzerland), with which Viromed Medical GmbH generated slightly less than half of its annual revenue in the 2023 financial year. Already in the past, various manufacturers of comparable devices had expressed interest in cooperating with Viromed Medical GmbH. However, given the exclusivity agreement with terraplasma medical GmbH, Viromed Medical GmbH was unable to take advantage of these opportunities. This restriction now no longer applies, so that Viromed Medical AG sees the possibility of expanding its sales potential in future by selling its own cold plasma devices worldwide. Viromed Medical AG plans to be present on the market with its own cold plasma product series at the beginning of the fourth quarter of 2024. As a first step, Viromed Medical AG is planning to enter the European market. Uwe Perbandt End of Inside Information
05-Jul-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Viromed Medical AG |
| Flensburger Straße 18 | |
| 25421 Pinneberg | |
| Germany | |
| Phone: | +49 4101 809960 |
| E-mail: | kontakt@viromed-medical.de |
| Internet: | https://www.viromed-medical-ag.de/ |
| ISIN: | DE000A3MQR65 |
| WKN: | A3MQR6 |
| Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg |
| EQS News ID: | 1940807 |
| End of Announcement | EQS News Service |
|
|
1940807 05-Jul-2024 CET/CEST
